SCHEMBL3261996

SCHEMBL3261996

CCCC(C(=O)O)(c1ccccc1)C(F)(F)F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.42
CYP2C19 P33261 4/20 0.42
LMNA P02545 4/20 0.42
CYP2D6 P10635 3/20 0.42
CYP3A4 P08684 3/20 0.42
SCN1A P35498 3/20 0.42
SCN2A Q99250 3/20 0.42
SCN3A Q9NY46 3/20 0.42
CYP2C9 P11712 2/20 0.42
TSHR P16473 1/20 0.42
NFKB1 P19838 1/20 0.42
MTOR P42345 1/20 0.42
RAB9A P51151 1/20 0.42
SIGMAR1 Q99720 1/20 0.42
NPSR1 Q6W5P4 2/20 0.41
NR1I2 O75469 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
CYP1A1 P04798 1/20 0.41
CYP2E1 P05181 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4551817 0.85 CYP1A2 (0.41) CYP1A2CYP2C19CYP2D6CYP3A4TSHR
SCHEMBL12837474 0.79 CYP1A2 (0.42) CYP1A2CYP2C19LMNACYP2D6CYP3A4
SCHEMBL27914577 0.78 CYP2C19 (0.41) CYP1A2CYP2C19LMNACYP2D6CYP3A4
SCHEMBL27788517 0.77 CYP2C19 (0.38) CYP1A2CYP2C19LMNACYP2D6CYP3A4
SCHEMBL4002970 0.77 TSHR (0.53) CYP1A2CYP2C19LMNACYP2D6CYP3A4
SCHEMBL6017231 0.77 KIF11 (0.45) CYP1A2CYP2C19LMNACYP2D6CYP3A4
SCHEMBL1843172 0.77 KIF11 (0.43) CYP1A2CYP2C19LMNACYP2D6CYP3A4
SCHEMBL19812940 0.76 CYP2C19 (0.44) CYP1A2CYP2C19CYP2D6CYP3A4TSHR
SCHEMBL2699401 0.75 MAPT (0.48) CYP2C19LMNACYP2D6KDM4EKMT2A
SCHEMBL29010044 0.75 CYP1A2 (0.38) CYP1A2CYP2C19LMNACYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367700-B2 Substituted 4-(1.2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2013-02-05 US disclosed
US-20100152234-A1 Substituted 4-(1,2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators GRUNENTHAL GMBH (DE) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152234-A1 Substituted 4-(1,2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators KCNAB1, KCNQ2, KCNQ1 CYP1A2 804/4885CYP2C19 1388/4885LMNA 2050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.